Rubedo Life Sciences

Age-related drug discovery platform

RBO-0987 RD age-related chronic dermatitis, undisclosed; RBO-1597 RD fibrosis; undisclosed RD frailty, sarcopenia

Rubedo Life Sciences is discovering and developing medicines that can improve biological health. During aging, cells become less functional due to the accumulation of damage with some becoming pathogenic, known as senescent cells. Rubedo is using their AI-driven drug discovery platform to identify compounds that can selectively target these senescent cells, while preserving healthy cells, to rejuvenate tissues and reverse disease progression. Ultimately, Rubedo aims to create the universal medicine that provides longevity and youth and cures all diseases.